|
|
|
Volumn 8, Issue 10, 2010, Pages 680-682
|
|
HPV and its effect on head and neck cancer prognosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CETUXIMAB;
CISPLATIN;
TAXANE DERIVATIVE;
WART VIRUS VACCINE;
ANUS DYSPLASIA;
ARTICLE;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL DECISION MAKING;
CLINICAL TRIAL;
DNA VIRUS INFECTION;
DRUG EFFICACY;
DRUG MEGADOSE;
DYSPLASIA;
GENITAL TRACT CANCER;
HEAD AND NECK CANCER;
HUMAN;
HUMAN PAPILLOMAVIRUS TYPE 16;
NONHUMAN;
OROPHARYNX CANCER;
OUTCOME ASSESSMENT;
PROGNOSIS;
QUALITY OF LIFE;
RADIATION DOSE;
RADIOSENSITIZATION;
SEXUAL BEHAVIOR;
SEXUALLY TRANSMITTED DISEASE;
SMOKING;
UTERINE CERVIX CANCER;
VAGINA CANCER;
VIRUS CARCINOGENESIS;
VIRUS DETECTION;
VULVA CANCER;
WART VIRUS;
CLINICAL TRIALS AS TOPIC;
HEAD AND NECK NEOPLASMS;
HUMANS;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
PROGNOSIS;
|
|
EID: 78649919931
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (27)
|
|
References (0)
|
